Lambert Center for the Study of Medicinal Cannabis & Hemp

2018 JAZ Tank Challenge: CannaVATION Edition

October 3rd, 2018

JAZ® Tank is back for its fourth year and Jefferson Innovation is asking individuals to tap into their inner inventor for the October 3 JAZ® Tank: CannaVATION.     

Presented by Jefferson Innovation and the Lambert Center for the Study of Medicinal Cannabis and Hemp at Jefferson, JAZ® Tank: CannaVATION invites staff, faculty, students and alumni from all of our campuses, as well as the general public, to submit their business models for a medicinal cannabis or industrial hemp product or service.  

A panel of judges will review submissions and select finalists to present their business ideas in a 10-minute pitch at Thomas Jefferson University on Wednesday, October 3, for the Grand Prize package* which includes:

Cash – $10,000 in Financial Support*

Legal Support – One Free Provisional or Utility Patent Application

Consultation – Business and Clinical Consulting Services to Build Your Business

* JAZ® reserves the right to award additional prizes

See JAZ® Tank featured on NBC10.

Spinal Cord Injury and Cannabis Program

April 4, 2018

We are now supporting a spinal cord injury and cannabis program developed by Dr. Dan Graves and his team at the Department of Rehabilitation Medicine.

This project is a three-part approach to providing a foundation for cannabis clinical trials. This proposal combines the long history of the Department of Rehabilitation Medicine and the expertise of the Lambert Center to systematically prepare a foundation for the conduct of clinical trials. Chronic neuropathic pain is a condition experienced by a majority of patients with SCI. However, the research environment for the study of cannabis in SCI is limited. The three sections of this proposal will provide a solid foundation on which to build these trials.

  1. The Consumer Training in Research Ethics and Scientific Information on Medical Applications of Cannabis had it first meeting on March 20, 2018, to integrate the patient voice into research design. A selected group of patients with SCI attended this training, which will become an integral component of future research.
  2. The large survey of knowledge, experience and attitudes concerning cannabis will inform the research team as to the issues that need to be addressed in recruitment and conduct clinical trials.
  3. The final component will be an in depth investigation of the differences in physical health, quality of life, community participation and cognition in self-selected groups of current cannabis users, past cannabis users and non-cannabis users. This will provide needed information for the research team to select possible research questions and potential outcome measures.

For more information contact us, at

Ex-NFL Players Attend Lambert Center Meeting to Discuss Medical Marijuana

May 2, 2017

During a three-day summit at the Union League of Philadelphia, attendees of various backgrounds from around the world gathered to discuss medical marijuana. Three former NFL players and one former NHL player joined on the second day of the summit. Players in attendance were Todd Herremans, former offensive lineman for the Eagles; Lance Johnston, former defensive end for the Oakland Raiders and Minnesota Vikings; Marques Colston, former wide receiver for New Orleans Saints; and Riley Cote, hemp advocate and once an enforcer for the Flyers.

Lambert Center Entrepreneurship & Social Impact Initiative Member, Lindy Snider, Invests in Medical Marijuana

February 22, 2017

Lindy Snider, whose late father, Ed Snider, benefited from medical cannabis when he had metastatic bladder cancer, is dully supporting the shift in Pennsylvania's medical marijuana industry. During the last few months of her father's life, his appetite dwindled but cannabis soon restored that.  

Along with being a member of the Entrepreneurship and Social Impact Initiative for The Lambert Center, Snider has a startup called Lindi Skin (skin care products for cancer patients) and serves on the board for KIND Financial (cannabis industry banking).  

Snider's goal is to build a 125,000-square-foot cannabis growing facility near the Bucks County line that would employ up to 50 people. If the Pennsylvania Department of Health accepts her application, which is due by March 20th, marijuana production would begin in 2018. Snider has been deemed a front-runner in a pool of about 800 applicants. 

Jefferson Receives $1.5 Million from Six Organizations to Support Cannabis Research & Education

December 22, 2016

The Lambert Center for the Study of Medicinal Cannabis and Hemp, funded entirely through philanthropy, has received a combined $1.5 million from six Pennsylvania organizations.

“We are recognizing these organizations as our ‘Founding Supporters’, because these gifts are enabling us to build the research infrastructure of The Lambert Center,” said Charles V. Pollack Jr., MA, MD, Director of Jefferson’s Institute of Emerging Health Professions. “We are very grateful for this cascade of generosity. It’s a strong vote of confidence in this unique academic endeavor.” 

The initial six Founding Supporters are: The Tuttleman Family Foundation, PharmaCannis, PA Options for Wellness, Commonwealth Alternative Medicinal Options, Keystone Wellness Research Fund, LLC, and Oha Wellness.

This support will drive educational initiatives and unbiased medical cannabis research.

IEHP receives $3 Million from Australian Philanthropist, Barry Lambert

December 7, 2016

The Center of Cannabis Research and Education (CMCER) has been renamed to The Lambert Center for the Study of Medicinal Cannabis and Hemp at Thomas Jefferson University.

Barry Lambert, 70, is renowned in the Australian banking industry for founding Count Financial, Australia’s largest network of accounting-based advisory firms. It was the love only a grandparent can feel that inspired the Lamberts’ philanthropy. As an infant, Barry and Joy’s granddaughter, Katelyn, was diagnosed with Dravet’s syndrome, a rare genetic abnormality that affects the brain's electric signaling system and causes severe and repetitive seizures. Medical cannabis has been shown to be one of the few therapies that mitigates the seizures caused by the condition, and cannabis derived from hemp indeed gave Katelyn substantial relief. The Lamberts’ gift reflects a belief that more study into medicinal cannabis will offer greater hope for others with this and other diverse conditions.

For more media coverage:

Philadelphia Magazine
Philadelphia Business Journal
Philly Voice
Philadelphia Inquirer